CRNX - Crinetics Pharmaceuticals, Inc.
IEX Last Trade
53.69
0.080 0.149%
Share volume: 8,980
Last Updated: Thu 26 Dec 2024 08:29:16 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$53.61
0.08
0.15%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-12 | 2022-11-14 | 2023-02-28 | 2023-05-09 | 2023-08-08 | 2023-11-07 | 2024-02-28 | 2024-05-09 | |
| Total revenue | 439.000 K | 458.000 K | 709.000 K | 2.679 M | 988.000 K | 346.000 K | 0.000 | 640.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 439.000 K | 458.000 K | 709.000 K | 2.679 M | 988.000 K | 346.000 K | 0.000 | 640.000 K | |
| 4.33% | 54.80% | 277.86% | -63.12% | -64.98% | -100.00% | inf% | |||
| Operating expenses | 43.484 M | 43.912 M | 48.265 M | 50.657 M | 53.983 M | 59.323 M | 62.658 M | 74.169 M | |
| Selling general and admin | 10.489 M | 11.925 M | 11.274 M | 12.189 M | 13.343 M | 15.484 M | 17.078 M | 20.828 M | |
| Research and development | 32.995 M | 31.987 M | 36.991 M | 38.468 M | 40.640 M | 43.839 M | 45.580 M | 53.341 M | |
| Total expenses | 43.484 M | 43.912 M | 48.265 M | 50.657 M | 53.983 M | 59.323 M | 62.658 M | 74.169 M | |
| 0.98% | 9.91% | 4.96% | 6.57% | 9.89% | 5.62% | 18.37% | |||
| Operating income | -43.045 M | -43.454 M | -47.556 M | -47.978 M | -52.995 M | -58.977 M | -62.658 M | -73.529 M | |
| Ebit | -43.045 M | -43.454 M | -47.556 M | -47.978 M | -52.995 M | -58.977 M | -62.658 M | -73.529 M | |
| Pretax income | -42.375 M | -41.925 M | -44.991 M | -45.995 M | -50.979 M | -57.458 M | -60.097 M | -66.930 M | |
| -1.06% | 7.31% | 2.23% | 10.84% | 12.71% | 4.59% | 11.37% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -42.375 M | -41.925 M | -44.991 M | -45.995 M | -50.979 M | -57.458 M | -60.097 M | -66.930 M | |
| 1.06% | -7.31% | -2.23% | -10.84% | -12.71% | -4.59% | -11.37% | |||
| Net income | -42.375 M | -41.925 M | -44.991 M | -45.995 M | -50.979 M | -57.458 M | -60.097 M | -66.930 M | |
| 1.06% | -7.31% | -2.23% | -10.84% | -12.71% | -4.59% | -11.37% |